Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-08-067570
Filing Date
2008-11-03
Accepted
2008-11-03 14:29:59
Documents
2
Period of Report
2008-09-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a08-27525_18ka.htm 8-K/A 19146
2 EX-16.1 a08-27525_1ex16d1.htm EX-16.1 4849
  Complete submission text file 0001104659-08-067570.txt   25584
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
Synergy Pharmaceuticals, Inc. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 333-131722 | Film No.: 081157089
SIC: 5990 Retail-Retail Stores, NEC